Get startedLog in
    Picture of Human Metabolome Technologies logo

    6090 — Human Metabolome Technologies Cashflow Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareBalancedMicro CapFalling Star
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Human Metabolome Technologies, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.

    2021
    June 30th
    2022
    June 30th
    2023
    June 30th
    2024
    June 30th
    2025
    June 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    JAS
    JAS
    JAS
    JAS
    JAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line50.9262237262270
    Depreciation
    Non-Cash Items37.3-27.84.7-11.2-14.5
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-17825-37.1-10014.5
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Taxes Payable
    Other Operating Cash Flow
    Cash from Operating Activities-34.2324285237374
    Capital Expenditures-27.9-146-117-34.1-149
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items1.88-6.20.11.66-48.5
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-26-152-117-32.4-197
    Financing Cash Flow Items—-0.001-0.001-0.001-0.002
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities86.280.5-13.8-73.2-369
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash26260152132-194